0.93 USD
↗ 0.01 (1.47%)AT CLOSE (03:59 PM EDT)
Estrella Immunopharma, Inc. Common Stock
ESLANASDAQ • USD
0.89
↘ 0.05 (4.97%)
POST MARKET (AS OF 05:58 PM EDT)
Post Market
AS OF 05:58 PM EDT
0.89
↘ 0.05 (4.97%)
Market: OPEN
ESLA is currently priced at $0.89. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (134.7%) and a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Oct 27, 2026.
Open?$0.88
High?$0.95
Low?$0.85
Prev. Close?$0.92
Volume?609.7K
Avg. Volume?3.7M
VWAP?$0.91
Rel. Volume?0.16x
Bid / Ask
Bid?$0.78 × 100
Ask?$1.10 × 100
Spread?$0.32
Midpoint?$0.94
Valuation & Ratios
Market Cap?40.0M
Shares Out?43.5M
Float?15.1M
Float %?35.2%
P/E Ratio?N/A
P/B Ratio?-5.39
EPS?-$0.23
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
Employees
N/A
Market Cap
40.0M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2023-10-02
Address
5858 HORTON STREET, SUITE 370
EMERYVILLE, CA 94608
Phone: (510) 318-9098
EMERYVILLE, CA 94608
Phone: (510) 318-9098
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?71
Piotroski F-Score?0/9Weak
Altman Z-Score?-51.91Distress
Confidence?46%Low
Short InterestLow
Short % of Float?3.96%Low
Short Interest?599.6K
Days to Cover?1.0
Free Float15.1M
Avg Daily Volume7.6M
Settlement Date2026-10-15
Financial Health
Current Ratio?0.20Weak
Quick Ratio?0.20Weak
Cash Ratio?0.02Low
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-5.39CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-4.1CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?134.7%STRONG▾
Peers50
S&P97
ROA?-548.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-9383567
Enterprise Value?$39.9M
Fundamentals ratios updated end of day